World Cancer Day is an annual global event on February 4 to raise people’s awareness of cancer. The ‘We can. I can.’ Campaign for World Cancer Day 2016-2018 explores how everyone – as a collective or as individuals – can do their part to reduce the global burden of cancer.
The ability to affect patient outcomes is truly a team effort. ASCP has collaborated with other medical organizations to develop new guidelines in the fight against colorectal cancer and gastric cancer.
At the ASCP 2016 Annual Meeting, we invited internationally renowned public health expert Paul Farmer, MD, PhD, co-founder of Partners In Health (PIH), as presenter for the general session, Global Health of the Future. In that session, attendees heard from Dr. Farmer and other key leaders in the ASCP-led Partners for Cancer Diagnosis and Treatment in Africa and learned how they can get involved in making a global impact on patient care.
In other initiatives, ASCP’s emphasis on a multidisciplinary medical team seeks to break down silos that often exist in health systems to facilitate communication and improve patient outcomes. The curriculum ASCP developed to improve the diagnosis and treatment of Myelodysplastic Syndrome (MDS), an often deadly blood cancer, fostered interactive dialogue between the pathologists and other clinicians regarding diagnosis, classification, and clinical care of MDS patients. So have curricula that target the treatment of lung cancer—one of the most common cancers in the U.S. and Europe.
ASCP has also launched an evidence-based, online diagnostic (Dx) toolkit, supported by a grant from Genentech, which provides educational resources at the point of need to pathologists and medical laboratory professionals to enhance their understanding of the diagnosis and management of breast cancer.
In October 2015, the ASCP-led Cancer Diagnosis and Treatment in Africa initiative was announced by the White House and celebrated its one year anniversary in October 2016 with the official launch of the Butaro-ASCP project in Rwanda. In 2017, four additional sites are planned for telepathology deployment and the partnership has grown to include 18 current or potential country sites in the future.
In January 2016, the White House announced the Cancer Moonshot, and to recognize the one year anniversary, ASCP and other foundations are participating in a White House meeting to foster open innovation as a way to meet the goals, locally and abroad.
As we embark on 2017, ASCP re-dedicates itself to providing innovative education and advocacy so that pathologists and medical laboratory scientists are prepared to lead the fight against cancer into the future. In an ever-changing healthcare environment, pathologists and medical laboratory scientists need to adapt to survive—and thrive.
The Society is collaborating with the Union for International Cancer Control (UICC) on an ambitious new initiative, the C/Can 2025: City Cancer Challenge, to support cities to design, plan and implement cancer treatment solutions that meet the needs of their citizens and the national priorities for cancer control. The goal of the initiative is to build a collective movement of partners that can deliver sustainable, robust cancer treatment solutions in the majority of the world’s cities that have a population of more than one million people. The initiative was announced on Jan. 17 at the World Economic Forum in Davos, Switzerland. ASCP Chief Medical Officer Dan A. Milner, Jr., MD, MSc(Epi), attended the formal introduction of the first C/Can 2025 key learning cities at a dinner in Geneva, Switzerland, on Feb. 2. See photos of the event below.
Share your experiences in the fight against cancer by leaving a comment below. For further reading about World Cancer Day, click here.